Kyo Chul Lee - Search Results

Year	Number of Results
2003	2
2004	1
2006	1
2007	5
2009	3
2010	3
2012	3
2013	3
2014	4
2015	6
2016	5
2017	6
2018	11
2019	9
2020	8
2021	12
2022	16
2023	6
2024	4

1

KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Yoo RJ, Lee YS, Lee KC, Kim DW, Kim DY, Choe YS, Jeong JM. Yoo RJ, et al. Among authors: lee kc. Nucl Med Mol Imaging. 2022 Jun;56(3):114-126. doi: 10.1007/s13139-022-00744-8. Epub 2022 Apr 5. Nucl Med Mol Imaging. 2022. PMID: 35607629 Free PMC article. Review.

2

The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning.

Mushtaq S, Ae PJ, Kim JY, Lee KC, Kim KI. Mushtaq S, et al. Among authors: lee kc. Theranostics. 2023 Sep 25;13(15):5247-5265. doi: 10.7150/thno.88998. eCollection 2023. Theranostics. 2023. PMID: 37908724 Free PMC article. Review.

3

Cancer therapy by antibody-targeted Cerenkov light and metabolism-selective photosensitization.

Jo C, Ahn H, Kim JH, Lee YJ, Kim JY, Lee KC, Kang CS, Kim S. Jo C, et al. Among authors: lee kc. J Control Release. 2022 Dec;352:25-34. doi: 10.1016/j.jconrel.2022.10.014. Epub 2022 Oct 14. J Control Release. 2022. PMID: 36243234 Free article.

4

From molecules to medicine: thiol selective bioconjugation in synthesis of diagnostic and therapeutic radiopharmaceuticals.

Bibi I, Mushtaq S, Lee KC, Park JA, Kim JY. Bibi I, et al. Among authors: lee kc. Theranostics. 2024 Mar 25;14(6):2396-2426. doi: 10.7150/thno.95469. eCollection 2024. Theranostics. 2024. PMID: 38646656 Free PMC article. Review.

5

The Feasibility of ⁶⁴Cu-PSMA I&T PET for Prostate Cancer.

Lee CH, Lim I, Woo SK, Kim KI, Lee KC, Song K, Choi CW, Lim SM. Lee CH, et al. Among authors: lee kc. Cancer Biother Radiopharm. 2022 Aug;37(6):417-423. doi: 10.1089/cbr.2020.4189. Epub 2021 Jan 12. Cancer Biother Radiopharm. 2022. PMID: 33434438

6

Feasibility of Gd-Based prostate cancer targeted magnetic resonance agents using prostate specific membrane antigen.

Yang JU, Kim S, Ahn JH, Kim MH, Kil HS, Chi DY, Lee KC, Lee YJ, Park JA. Yang JU, et al. Among authors: lee kc. Biochem Biophys Res Commun. 2022 Jun 4;607:152-157. doi: 10.1016/j.bbrc.2022.03.136. Epub 2022 Mar 28. Biochem Biophys Res Commun. 2022. PMID: 35367828

7

64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.

Lee I, Lim I, Lee KC, Kang HJ, Lim SM. Lee I, et al. Among authors: lee kc. Clin Nucl Med. 2023 Feb 1;48(2):e82-e83. doi: 10.1097/RLU.0000000000004378. Epub 2022 Sep 21. Clin Nucl Med. 2023. PMID: 36127796

8

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis.

Jung KH, Lee YJ, Kim JY, Lee KC, Park JA, Choi JY. Jung KH, et al. Among authors: lee kc. J Vis Exp. 2019 Jan 7;(143). doi: 10.3791/58218. J Vis Exp. 2019. PMID: 30663663

9

Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice.

Oh SJ, Lee N, Nam KR, Kang KJ, Han SJ, Lee KC, Lee YJ, Choi JY. Oh SJ, et al. Among authors: lee kc. Front Neurosci. 2022 Aug 5;16:930613. doi: 10.3389/fnins.2022.930613. eCollection 2022. Front Neurosci. 2022. PMID: 35992913 Free PMC article.

10

Development of Brain-Tumor-Targeted Benzothiazole-Based Boron Complex for Boron Neutron Capture Therapy.

Yang JU, Kim S, Lee KC, Lee YJ, Kim JY, Park JA. Yang JU, et al. Among authors: lee kc. ACS Med Chem Lett. 2022 Sep 15;13(10):1615-1620. doi: 10.1021/acsmedchemlett.2c00284. eCollection 2022 Oct 13. ACS Med Chem Lett. 2022. PMID: 36262402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year